This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Cubist Pharmaceuticals Inc.
CBST : NASDAQ : Health Care

$63.95 | %
Today's Range: 63.04 - 65.32
Avg. Daily Volume: 916,700
04/17/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
CBST CUBIST PHARMACEUTICALS INC 67.37 5070.27 n/m 1054.44 13.82
BMRN BIOMARIN PHARMACEUTICAL INC 61.29 8884.84 n/m 548.49 9.53
INCY INCYTE CORP 47.13 7801.76 n/m 354.95 19.48
ICPT INTERCEPT PHARMA INC 264.68 5325.36 n/m 1.62 74.78
UTHR UNITED THERAPEUTICS CORP 96.15 4853.36 29.40 1116.98 21.93
SGEN SEATTLE GENETICS INC 39.37 4846.80 n/m 269.26 27.72
MDVN MEDIVATION INC 58.32 4451.80 n/m 272.94 50.21
ISIS ISIS PHARMACEUTICALS INC 35.98 4219.37 n/m 147.29 44.32
ALNY ALNYLAM PHARMACEUTICALS INC 57.92 3826.14 n/m 47.17 -29.32
GRFS GRIFOLS SA 38.62 16155.21 27.78 3777.83 9.31
VRTX VERTEX PHARMACEUTICALS INC 65.69 15510.26 n/m 1211.98 -20.64
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CBST Ind Avg S&P 500
n/m 43.67 18.29

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs